Viridian Therapeutics

IPO

Viridian - Framing the future of autoimmune diseases

Public · United States

Business Model
B2B
Type
Public

About

Clinical-stage biopharmaceutical company developing antibody therapies for thyroid eye disease (TED) targeting IGF-1R and TSHR.

Summary

Viridian Therapeutics is a Biotech company based in United States.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Debt FinancingRoyalty FinancingOct 2025
$55.0M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Viridian Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/viridian-therapeutics"><img src="https://indexed.vc/api/badge/company/viridian-therapeutics" alt="Viridian Therapeutics on Indexed.vc" width="260" height="76" /></a>